<SEC-DOCUMENT>0001193125-24-047076-index.html : 20240227 <SEC-HEADER>0001193125-24-047076.hdr.sgml : 20240227 <ACCEPTANCE-DATETIME>20240227073540 ACCESSION NUMBER: 0001193125-24-047076 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 7 FILED AS OF DATE: 20240227 DATE AS OF CHANGE: 20240227 EFFECTIVENESS DATE: 20240227 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001492422 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 271537290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-277381 FILM NUMBER: 24682002 BUSINESS ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-977-5700 MAIL ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 </SEC-HEADER> <DOCUMENT> <TYPE>S-8 <SEQUENCE>1 <FILENAME>d783393ds8.htm <DESCRIPTION>S-8 <TEXT> Document 1 - file: d783393ds8.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>d783393dex51.htm <DESCRIPTION>EX-5.1 <TEXT> Document 2 - file: d783393dex51.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.2 <SEQUENCE>3 <FILENAME>d783393dex232.htm <DESCRIPTION>EX-23.2 <TEXT> Document 3 - file: d783393dex232.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>4 <FILENAME>d783393dexfilingfees.htm <DESCRIPTION>EX-FILING FEES <TEXT> Document 4 - file: d783393dexfilingfees.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>g783393g0223225156437.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: g783393g0223225156437.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>g783393g0223225556708.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: g783393g0223225556708.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>g783393g0223231905953.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 7 - file: g783393g0223231905953.jpg
</DOCUMENT> </SEC-DOCUMENT>